New heart valve device under Real-World scrutiny

NCT ID NCT06535659

Summary

This study is tracking the safety and performance of the VitaFlow Liberty device, which replaces a narrowed aortic heart valve without open-heart surgery. It will follow 122 patients with severe aortic stenosis who are at high risk for traditional surgery. The main goal is to see how many patients are alive and free from disabling stroke one year after the procedure.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Galway University Hospital

    NOT_YET_RECRUITING

    Galway, Ireland

    Contact

  • Hospital Clínico San Carlos

    RECRUITING

    Madrid, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario de a Coruna

    RECRUITING

    A Coruña, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital clinico Universitario de Valladolid

    RECRUITING

    Valladolid, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Luzerner Kantonsspital | Herzzentrum

    RECRUITING

    Lucerne, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ospedale Cisanello

    RECRUITING

    Pisa, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.